A detailed history of Whalen Wealth Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 3,644 shares of ABT stock, worth $464,755. This represents 0.29% of its overall portfolio holdings.

Number of Shares
3,644
Previous 3,447 5.72%
Holding current value
$464,755
Previous $469 Million 4.11%
% of portfolio
0.29%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

BUY
$120.51 - $136.62 $23,740 - $26,914
197 Added 5.72%
3,644 $488 Million
Q2 2025

Aug 04, 2025

BUY
$123.95 - $138.08 $427,255 - $475,961
3,447 New
3,447 $469 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $223B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Whalen Wealth Management Inc. Portfolio

Follow Whalen Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalen Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whalen Wealth Management Inc. with notifications on news.